School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Bassel Nazha

  • Department of Hematology and Medical Oncology
    Assistant Professor
  • (404) 251-5996
  • bassel.nazha@emory.edu
Head shot of Bassel Nazha

Academic Appointment

  • Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from American University of Beirut
  • MPH from Columbia University

Research

Publications

  • Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.
    Oncologist Volume: 29 Page(s): 738 - 746
    09/06/2024 Authors: Chukkalore D; MacDougall K; Master V; Bilen MA; Nazha B
  • Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
    J Natl Cancer Inst Volume: 116 Page(s): 966 - 973
    06/07/2024 Authors: Rose KM; Pham R; Zacharias NM; Ionescu F; Paravathaneni M; Marchetti KA; Sanchez D; Mustasam A; Sandstrom R; Vikram R
  • Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
    Clin Genitourin Cancer Volume: 22 Page(s): 102056
    06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS
  • Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
    Cancer Volume: 129 Page(s): 3884 - 3893
    12/15/2023 Authors: Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI
  • Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Oncologist Volume: 28 Page(s): 1072 - 1078
    12/11/2023 Authors: Sanda GE; Shabto JM; Goyal S; Liu Y; Martini DJ; Nazha B; Brown JT; Yantorni LB; Anne Russler G; Caulfield S
  • The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
    Cancers (Basel) Volume: 15
    12/06/2023 Authors: Hadadi A; Krause HB; Elliott A; Brown JT; Nazha B; Harik LR; Carthon BC; Miron B; Nabhan C; Barata PC
  • Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
    J Natl Cancer Inst Volume: 115 Page(s): 1605 - 1615
    12/06/2023 Authors: El Zarif T; Nassar AH; Pond GR; Zhuang TZ; Master V; Nazha B; Niglio S; Simon N; Hahn AW; Pettaway CA
  • Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?
    J Clin Oncol Volume: 41 Page(s): 2467 - 2470
    05/10/2023 Authors: Brown JT; Nazha B; Bilen MA
  • Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 28 Page(s): 239 - 245
    03/17/2023 Authors: Zhuang TZ; Ravindranathan D; Liu Y; Martini DJ; Brown JT; Nazha B; Russler G; Yantorni LB; Caulfield S; Carthon BC
  • Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
    J Immunother Precis Oncol Volume: 5 Page(s): 52 - 57
    08/01/2022 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Hitron EE; Russler GA; Yantorni L; Caulfield S; Brown JT
  • Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis.
    Cancers (Basel) Volume: 14
    06/30/2022 Authors: Nazha B; Zhang C; Chen Z; Ragin C; Owonikoko TK
  • High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.
    Nat Commun Volume: 13 Page(s): 3385
    06/13/2022 Authors: Boya M; Ozkaya-Ahmadov T; Swain BE; Chu C-H; Asmare N; Civelekoglu O; Liu R; Lee D; Tobia S; Biliya S
  • Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.
    Cancers (Basel) Volume: 14
    06/10/2022 Authors: Zhuang TZ; Case K; Olsen TA; Brown JT; Carthon BC; Kucuk O; Goldman J; Harris W; Bilen MA; Nazha B
  • Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
    Oncologist Volume: 27 Page(s): 462 - 468
    06/08/2022 Authors: Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA
  • Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.
    Urol Oncol Volume: 40 Page(s): 271.e9 - 271.e18
    06/01/2022 Authors: Hadadi A; Smith KE; Wan L; Brown JR; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O
  • Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
    Clin Genitourin Cancer Volume: 20 Page(s): 53 - 59
    02/01/2022 Authors: Martini DJ; Evans ST; Liu Y; Shabto JM; Uner OE; Olsen TA; Brown JT; Russler GA; Yantorni L; Caulfield S
  • Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.
    Front Oncol Volume: 12 Page(s): 949400
    01/01/2022 Authors: Zhuang TZ; Harik L; Force S; Hadadi A; Bilen MA; Brown JT; Carthon BC; Goldman J; Kucuk O; Master VA
  • Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
    Front Endocrinol (Lausanne) Volume: 13 Page(s): 779915
    01/01/2022 Authors: Olsen TA; Zhuang TZ; Caulfield S; Martini DJ; Brown JT; Carthon BC; Kucuk O; Harris W; Bilen MA; Nazha B
  • Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 1017 - 1025
    12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
  • Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.
    Oncologist Volume: 26 Page(s): 956 - 964
    11/01/2021 Authors: Smith KER; Brown JT; Wan L; Liu Y; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O
  • Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): e1742 - e1750
    10/01/2021 Authors: Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA
  • Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    J Immunother Cancer Volume: 9
    07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
  • Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link?
    Cancer Volume: 127 Page(s): 1371 - 1373
    05/01/2021 Authors: Nazha B; Bilen MA
  • Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer.
    Future Oncol Volume: 17 Page(s): 965 - 977
    03/01/2021 Authors: Nazha B; Yang JC-H; Owonikoko TK
  • Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Front Oncol Volume: 11 Page(s): 707050
    01/01/2021 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
  • Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
    Front Oncol Volume: 11 Page(s): 701345
    01/01/2021 Authors: Olsen TA; Martini DJ; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
  • Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.
    J Immunother Cancer Volume: 8
    12/01/2020 Authors: Pakkala S; Higgins K; Chen Z; Sica G; Steuer C; Zhang C; Zhang G; Wang S; Hossain MS; Nazha B
  • Efficacy and safety of immune checkpoint blockade in self-identified Black patients with advanced non-small cell lung cancer.
    Cancer Volume: 126 Page(s): 5040 - 5049
    12/01/2020 Authors: Nazha B; Goyal S; Chen Z; Engelhart A; Carlisle JW; Beardslee TJ; Gill H; Odikadze L; Liu Y; Mishra MK
  • IMMUNE-RELATED ADVERSE EVENTS (IRAES) MAY INDICATE A FAVORABLE PROGNOSIS IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
    Volume: 8 Page(s): A380 - A381
    11/01/2020 Authors: Martini D; Evans S; Goyal S; Liu Y; Olsen TA; Magod B; Brown J; Yantorni L; Russler G; Caulfield S
  • BODY COMPOSITION MAY BE PROGNOSTIC AND PREDICTIVE OF CLINICAL OUTCOMES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
    Volume: 8 Page(s): A26 - A27
    11/01/2020 Authors: Martini D; Olsen TA; Goyal S; Liu Y; Evans S; Magod B; Brown J; Yantorni L; Russler G; Caulfield S
  • EFFICACY OF SEQUENTIAL IMMUNE CHECKPOINT INHIBITION (ICI) IN PATIENTS WITH GENITOURINARY MALIGNANCIES
    Volume: 8 Page(s): A154 - A155
    11/01/2020 Authors: Evans S; Martini D; Magod B; Olsen T; Brown J; Yantorni L; Ravindranathan D; Russler G; Caulfield S; Goldman J
  • Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.
    Front Oncol Volume: 10 Page(s): 1000
    01/01/2020 Authors: Nazha B; Inal C; Owonikoko TK
  • An unusual case of struma ovarii causing ovarian torsion during pregnancy.
    J Obstet Gynaecol Volume: 39 Page(s): 716 - 717
    07/01/2019 Authors: Khalife D; Nassif J; Nazha B; Khalifeh I; Khoury S; Khalil A
  • Evaluating the role of race in outcome of advanced non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitor (ICI): Our institutional experience.
    Volume: 37
    05/20/2019 Authors: Nazha B; Chen Z; Goyal S; Engelhart A; Carlisle JW; Beardslee T; Gill H; Odikadze L; Liu Y; Mishra MK
  • The clinical conundrum of managing relapsed small cell lung cancer.
    Cancer Volume: 125 Page(s): 1022 - 1026
    04/01/2019 Authors: Nazha B; Owonikoko TK
  • Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.
    Am Soc Clin Oncol Educ Book Volume: 39 Page(s): 3 - 10
    01/01/2019 Authors: Nazha B; Mishra M; Pentz R; Owonikoko TK
  • Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized Anticoagulation.
    Semin Thromb Hemost Volume: 44 Page(s): 813 - 822
    11/01/2018 Authors: Nazha B; Pandya B; Spyropoulos AC; Kessler CM
  • Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Circulation Volume: 138 Page(s): 1402 - 1411
    10/02/2018 Authors: Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
  • Neutrophil-to-Lymphocyte Ratio as Predictor for Hospital Mortality in Patients with Acute Pulmonary Embolism
    Volume: 197
    01/01/2018 Authors: Mansour W; Karam B; Zaidan J; Kfoury B; Abbasi S; El Bitar S; Nazha B; Esper Z; Chalhoub M
  • Heparin-Induced Thrombocytopenia: Are We Ordering Too Much
    Volume: 130
    12/07/2017 Authors: El Bitar S; Moussaly E; Abbasi S; Ghanem S; Nazha B; Garcia G; Terjanian T
  • Febrile neutropenia in the nationwide inpatient sample: In-hospital outcomes and impact of cormobidities in 2007-2012.
    Volume: 35
    05/20/2017 Authors: Abbasi S; Nazha B; Moussaly E; Manchanda M; Atallah JP
  • Soft Tissue Myoepithelial Carcinoma of the Neck with Spinal Invasion.
    Rare Tumors Volume: 8 Page(s): 6485
    09/05/2016 Authors: Moussaly E; Nazha B; Kedia S; Chang Q; Forte F
  • The BRIDGE trial: What the hospitalist should know.
    J Hosp Med Volume: 11 Page(s): 652 - 657
    09/01/2016 Authors: Nazha B; Spyropoulos AC
  • Anaplastic lymphoma kinase inhibitors in elderly patients with advanced non-small cell lung cancer.
    Expert Rev Anticancer Ther Volume: 16 Page(s): 877 - 883
    08/01/2016 Authors: Zaarour M; Nazha B; Weerasinghe C; Moussaly E; Terjanian T
  • Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?
    World J Gastrointest Surg Volume: 7 Page(s): 370 - 377
    12/27/2015 Authors: Nazha B; Moussaly E; Zaarour M; Weerasinghe C; Azab B
  • Primary Non-Hodgkin's Lymphoma of the Spine: A Case Report and Literature Review.
    World J Oncol Volume: 6 Page(s): 459 - 463
    10/01/2015 Authors: Moussaly E; Nazha B; Zaarour M; Atallah JP
  • Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.
    Case Rep Hematol Volume: 2015 Page(s): 161764
    01/01/2015 Authors: Nazha B; Garcia G; Kandov R; Odaimi M
  • Students' perceptions of peer-organized extra-curricular research course during medical school: a qualitative study.
    PLoS One Volume: 10 Page(s): e0119375
    01/01/2015 Authors: Nazha B; Salloum RH; Fahed AC; Nabulsi M
  • Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer.
    Expert Rev Anticancer Ther Volume: 15 Page(s): 1327 - 1336
    01/01/2015 Authors: Zaarour M; Weerasinghe C; Nazha B; Hassan S; Atallah J-P
  • Aberrant nuclear repressor coreceptor 1 localization in human retinoblastoma.
    Ophthalmic Res Volume: 49 Page(s): 171 - 176
    01/01/2013 Authors: Nazha B; Granner T; Maloney S; Odashiro AN; Antecka E; Burnier MN
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements